Mark Honigsbaum. Show Affiliations »
Abstract
Mesh: See more » Anti-Bacterial Agents/pharmacologyAnti-Bacterial Agents/therapeutic useBacteria/drug effectsBiological EvolutionCross Infection/drug therapyCross Infection/microbiologyDrug Resistance, MicrobialHumansPractice Patterns, Physicians'
Substances: See more » Anti-Bacterial Agents
Year: 2018 PMID: 29407025 DOI: 10.1016/S0140-6736(18)30110-7
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321